SCR Financial Facts

See Full Income Statement

See Full Balance Sheet

Simcere Pharmaceutical Group. (SCR) Earnings

  |   Expand Research on SCR
Next EPS Date 7/13/21 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -23.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +2.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/13/21 Q221 -Cdn$0.45N/A N/A Cdn$5.59MCdn$6.65M N/A Details
11/14/13 Q313 $0.51N/A N/A $68.8M$78.5M N/A Details
8/13/13 Q213 $0.03$0.12 -$0.09$78.7M$91.58M N/A Details
5/9/13 Q113 RMB0.56N/A N/A RMB528.73MRMB487.61M N/A Details
3/7/13 Q412 -$0.06$0.00 -$0.06$86.7M$88.06M N/A Details
11/15/12 Q312 $0.07$0.07 $0.00$83.8M$85.72M N/A Details
8/10/12 Q212 $0.08$0.10 -$0.02$83.2M$86.83M N/A Details
5/9/12 Q112 $0.08$0.10 -$0.02$77.4M$84.31M N/A Details